Business description of Structure-Therapeutics-Inc from last 10-k form

The information required by this item will be set forth in the Proxy Statement in the section headed “Election of Directors,” “Information Regarding the Board and Corporate Governance,” and “Delinquent Section 16(a) Reports,” if any, and is incorporated herein by reference.

We have adopted a Code of Business Conduct and Ethics that applies to all officers, directors and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A current copy of the Code of Business Conduct and Ethics is available on the Corporate Governance section of our website at www.structuretx.com. To the extent required by rules adopted by the SEC, we will promptly disclose future amendments to our Code of Business Conduct and Ethics or waivers of its requirements that apply to our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions on our website. The information contained on our website is not considered part of, or incorporated by reference into, this Annual Report on Form 10-K or any other filing that we make with the SEC.

Item 11. Executive Compensation.

The information required by this item will be set forth in the Proxy Statement in the sections headed “Executive Compensation” and “Information Regarding the Board and Corporate Governance,” and is incorporated herein by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The information required by this item will be set forth in the Proxy Statement in the section headed “Security Ownership of Certain Beneficial Owners and Management,” and “Securities Authorized for Issuance Under Equity Compensation Plans,” and is incorporated herein by reference.

Item 13. Certain Relationships and Related Transactions, and Director Independence

The information called for by this item will be set forth in the Proxy Statement in the section headed “Transactions with Related Persons,” and “Information Regarding the Board and Corporate Governance,” and is incorporated herein by reference.

Item 14. Principal Accountant Fees and Services.

The information required by this item will be set forth in the Proxy Statement in the section headedPrincipal Accountant Fees and Services” and is incorporated by reference.

208

PART IV

Item 15. Exhibits, Financial Statement Schedules.

The following documents are filed as part of this Annual Report on Form 10-K:

(1) FINANCIAL STATEMENTS

Our financial statements are listed in the “Index to the Financial Statements” under Part II, Item 8, “Financial Statements and Supplementary Data” of this Annual Report on Form 10-K.

(2) FINANCIAL STATEMENT SCHEDULES

All schedules to the financial statements are omitted because they are not applicable, not material or the required information is shown in Part II, Item 8, “Financial Statements and Supplementary Data” of this Annual Report on Form 10-K.

(3) EXHIBITS

The documents listed in the Exhibit Index of this Annual Report on Form 10-K are incorporated by reference or are filed with this Annual Report on Form 10-K, in each case as indicated therein.

209

Exhibit Number

Exhibit Number

Description of Document

Description of Document

Form

Form

File No.

File No.

Exhibit

Exhibit

Filing Date

Filing Date

Filed Herewith

Filed Herewith

3.1

3.1

8-K

8-K

001-41608

001-41608

3.1

3.1

February 7, 2023

February 7, 2023

4.1

4.1

S-1/A

S-1/A

333-269200

333-269200

4.1

4.1

January 30, 2023

January 30, 2023

4.2

4.2

S-1/A

333-269200

4.2

4.2

January 30, 2023

4.3

4.3

S-1/A

S-1/A

333-269200

333-269200

4.3

4.3

January 30, 2023

January 30, 2023

4.4

4.4

S-1

S-1

333-269200

4.4

4.4

January 12, 2023

January 12, 2023

4.5

4.5

.

.

8-K

8-K

001-41608

001-41608

4.1

4.1

September 29, 2023

September 29, 2023

4.6

4.6

10-K

10-K

001-41608

4.5

4.5

March 30, 2023

March 30, 2023

10.1+

10.1+

S-1

S-1

333-269200

10.1

10.1

January 12, 2023

January 12, 2023

10.2+

10.2+

S-1

333-269200

10.2

10.2

January 12, 2023

10.3+

10.3+

.

10-K

10-K

001-41608

10.3

10.3

March 30, 2023

March 30, 2023

10.4+

10.4+

S-1

333-269200

10.4

10.4

January 12, 2023

10.5+

10.5+

S-1

333-269200

10.5

10.5

January 12, 2023

10.6+

10.6+

S-1

333-269200

10.6

10.6

January 12, 2023

210

10.7+

10.7+

S-1

333-269200

10.7

10.7

January 12, 2023

10.8+

10.8+

S-1

333-269200

10.8

10.8

January 12, 2023

10.9+

10.9+

.

.

10-K

001-41608

10.9

10.9

March 30, 2023

10.10+

10.10+

S-1

333-269200

10.10

10.10

January 12, 2023

10.11+

10.11+

S-1

333-269200

10.11

10.11

January 12, 2023

10.12+

10.12+

S-1

333-269200

10.12

10.12

January 12, 2023

10.13+

10.13+

S-1

333-269200

10.13

10.13

January 12, 2023

10.14+

10.14+

S-1

333-269200

10.15

10.15

January 12, 2023

10.15+

10.15+

S-1

333-269200

10.16

10.16

January 12, 2023

10.16+

10.16+

S-1

333-269200

10.17

10.17

January 12, 2023

10.17+

10.17+

8-K

001-41608

10.1

August 4, 2023

August 4, 2023

10.18+

10.18+

S-1

333-269200

10.23

10.23

January 12, 2023

10.19*

10.19*

S-1

333-269200

10.24

10.24

January 12, 2023

211